R J Barth Jr
Overview
Explore the profile of R J Barth Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
573
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pipas J, Zaki B, McGowan M, Tsapakos M, Ripple G, Suriawinata A, et al.
Ann Oncol
. 2012 May;
23(11):2820-2827.
PMID: 22571859
Background: Neoadjuvant therapy has been investigated for localized and locally advanced pancreatic ductal adenocarcinoma (PDAC) but no standard of care exists. Combination cetuximab/gemcitabine/radiotherapy demonstrates encouraging preclinical activity in PDAC. We...
2.
Gibson G, Lesnikoski B, Yoo J, Mott L, Cady B, Barth Jr R
Ann Surg Oncol
. 2001 Oct;
8(9):693-704.
PMID: 11597009
Background: Excising a breast tumor with negative margins minimizes local recurrence. With a positive margin, the standard re-excision consists of excising the whole cavity and all surrounding breast tissue. By...
3.
Pipas J, Mitchell S, Barth Jr R, Rathmann J, Meyer L, Wagman R, et al.
Int J Radiat Oncol Biol Phys
. 2001 Aug;
50(5):1317-22.
PMID: 11483344
Purpose: To determine the maximum tolerated dose and dose-limiting toxicity associated with twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas. Methods And Materials: Twenty-one patients...
4.
Lambert L, Gibson G, Maloney M, Barth Jr R
J Immunother
. 2001 Jun;
24(3):232-6.
PMID: 11394500
Multiple clinically applicable methods have been used to induce dendritic cells (DCs) to express whole cell tumor antigens, including pulsing DCs with tumor lysate, and mixing DCs with apoptotic or...
5.
Schwaab T, Weiss J, Schned A, Barth Jr R
J Immunother
. 2001 Mar;
24(2):130-7.
PMID: 11265770
We quantitatively evaluated dendritic cell (DC) infiltration in primary colorectal cancers from 44 patients and metastatic colorectal tumors from 13 patients using immunohistochemistry for the DC marker CD83, HLA-DR, and...
6.
Lambert L, Gibson G, Maloney M, Durell B, Noelle R, Barth Jr R
Cancer Res
. 2001 Feb;
61(2):641-6.
PMID: 11212262
We developed a technique for direct inguinal lymph node injection in mice to compare various routes of immunization with tumor lysate-pulsed dendritic cell (DC) vaccines. Syngeneic, bone marrow-derived, tumor lysate-pulsed...
7.
Lambert L, Colacchio T, Barth Jr R
Arch Surg
. 2000 Apr;
135(4):473-9; discussion 479-80.
PMID: 10768715
Hypothesis: Interval reevaluation for resectability of hepatic colorectal metastases aids patient selection. Design: A retrospective review. Setting: A tertiary care medical center. Patients And Methods: From January 1, 1985, to...
8.
Barth Jr R
Breast Cancer Res Treat
. 2000 Jan;
57(3):291-5.
PMID: 10617306
Background: Pathologists can distinguish benign phyllodes tumors, which very rarely metastasize, from malignant phyllodes tumors, which metastasize in approximately one fourth of patients. However, whether these same histologic criteria can...
9.
Mackey M, Gunn J, Maliszewsky C, Kikutani H, Noelle R, Barth Jr R
J Immunol
. 1998 Sep;
161(5):2094-8.
PMID: 9725199
A critical role for CD40/CD154 interactions in the generation of protective cell-mediated tumor immunity has been demonstrated previously. Herein, we show that the failure to generate systemic tumor immunity in...
10.
Mackey M, Barth Jr R, Noelle R
J Leukoc Biol
. 1998 Apr;
63(4):418-28.
PMID: 9544571
This review focuses on the emerging body of literature suggesting a critical role for CD40/CD154 interactions in antigen-presenting cell (APC) activation, CD4+ and CD8+ T cell priming, and effector T...